Seattle, WA (PRWEB) December 12, 2013
The global outplacement firm Challenger, Grey & Christmas reported that recently December has been experiencing comparatively small job-cut totals since the end of the recession. They also mentioned that the November job cuts were 21 percent lower than the same month last year and lower than employers were expecting. (challengergray.com, 12/5/13) This has been especially good news for many companies attempting to branch out in research and development areas.
"When people hear the phrase 'gains in Healthcare' they may automatically assume the benefits will be confined to the traditional patient care areas that are presented to the public. Clearly those are vital areas which will also see the benefit. However, as technology has become more of an intrinsic part of the way we research in the Healthcare Industry, gains within that industry have further reaching ramifications than merely within doctor's offices and hospitals. Biotechnology, Pharmaceutical technology and many other areas of sales, research and business will also see gains as a result," says Del Johnston, Manager of Client Relations at MedZilla.com.
With the availability of Gardasil and Cervarix helping to protect women against cervical cancers (cdc.gov/hpv/vaccine.html), researchers in the biotech industry have been looking into branching out and looking into the potentials of what other cancers might also be prevented with a vaccine. The concept of a series of vaccinations which could lower the risk in patients of some of the most deadly cancers has many researchers very interested in what potential might exist.
In central Massachusetts, Eric von Hofe is now preparing to have his data reviewed from studies he has b
Copyright©2012 Vocus, Inc.
All rights reserved